Tag Search Results: Breast cancer

Cancer originating in breast tissue, usually in the ducts and lubules of the breast.

Knowledge Center (22)

# Title Description
1Assessment of Prognostic and Predictive Factors in Breast Cancer ... ... Factors in Breast Cancer by Immunohistochemistry D. Craig Allred, MD Breast Center, Baylor College of Medicine, Houston Texas Most ...
2Topoisomerase II Alpha and Chemotherapy Selection for Breast ... ... to measure amplification or deletion of this gene in breast cancer specimens. ” ... Topoisomerase II Alpha and Chemotherapy Selection for Breast Cancer ...
3Pre-analytic Variables, Breast Cancer Testing and Adjuvant ... ... However, if the laboratory uses a formalin Pre-analytic Variables, Breast Cancer Testing ... Diagnosed with Breast Cancer David G. Hicks, MD ...
4Molecular vs. Immunohistochemical Classification of Breast Cancer... Molecular vs. Immunohistochemical Classification of Breast Cancer A re ... which Breast Cancer Page 2. Connection 2009 | 29 actually ...
5Difference of Biomarker Expression Among Primary Tumor and Brain ... ... The incidence of symptomatic brain metastases in metastatic breast cancer ranges from 10 to 16%. ... Profiles of Resected Brain Metastases from Breast Cancer ...
6Opinion ASCO-CAP HER2 Testing Guidelines and Validation Studies*... I n the Spring of 2006 an historic consensus conference to discuss HER2 testing in breast cancer was held in Alexandria, Virginia, bringing together oncologists ...
7Connection 11 - Standardization of HER2 Testing - Inconsistency ... ... An expert in the field of breast pathology, Dr. Badve is Associate Profes- sor in the Department of Pathology and Laboratory Medicine with ad- ditional ...
8Article Pharmacodiagnostic in Breast Cancer... Article Pharmacodiagnostic in Breast Cancer ... 3. Turner NC, Reis-Filho JS: Basal-like breast cancer and the BRCA1 phenotype. Oncogene 2006;25(43):5846-5853. ...
9Epidermal Growth Factor Receptor in Breast Carcinoma:An OverviewPage 1. | Connection 2009 40 Epidermal Growth Factor Receptor in Breast Carcinoma:An Overview Rohit Bhargava, MD ... Breast Cancer Page 2. Connection 2009 | ...
10Molecular Classifications of Breast Carcinoma: Is ... ... Molecular Classifications of Breast Carcinoma: Is Immunohistochemistry a Viable Alternative to Other Molecular Methodologies? ... Breast Cancer Page 2. ...
11Recent Developments in the Molecular Pathology of Breast Cancer... Recent Developments in the Molecular Pathology of Breast Cancer Peter Simpson, PhD Sunil R Lakhani, MD, FRCPath (UK), FRCPA (Aus) ... Breast Cancer Page 2. ...
12Telomere-Mediated Genomic Instability and the Clinico-Pathological ... ... and the Clinico-Pathological Parameters in Breast Cancer ... Introduction Breast cancer is the most common cause of cancer deaths among women worldwide. ...
13Dako Scientific Magazine - Connection 12... Dec 01, 2008. Pharmacodiagnostic in Breast Cancer. Dec 01, 2008. Topoisomerase II Alpha and Chemotherapy Selection for Breast Cancer. Dec 01, 2008. ...
14HER2/ neu Status is an Important Biomarker in Guiding Personalized ... ... kDa range and has been shown to be circulating in the serum or plasma of normal individuals and to be elevated in the circulation of patients with breast cancer ...
15Overview of HER2 IQFISH pharmDx™... Intended for use for breast and gastric cancer indications. ... HER2 IQFISH pharmDx™, HER2/CEN-17, Breast/Gastric, K5731. Dako Breast Panel, Dako Gastric Panel, ...
16Dako Scientific Magazine - Connection 9... 9 are available below: Connection Vol. 9 Articles. Assessment of Prognostic and Predictive Factors in Breast Cancer by Immunohistochemistry. Jun 01, 2006. ...
17HercepTest™ Interpretation Guides... HercepTest™ Interpretation Guides. HercepTest™ Interpretation Manual - Breast Literature Order No. 29036. This HercepTest™ Interpretation ...
18Milestones in the Discovery of HER2 Proto-Oncogene and Trastuzumab ... ... Sunil S. Badve, MD, FRCPath An expert in the field of breast pathology, Dr. Badve is an Associate Professor at the Department of Pathology and Laboratory ...
19ER/PR pharmDx™ Interpretation GuideDako. United States of America; Contact. Welcome; Login; Register. Home; Products; Services & Support; Knowledge Center; About Dako. My Cart (0). ...
20Connection 9... Page 3. From Us Global Perspectives on the Fight Against Breast Cancer ... Assessment of Prognostic and Predictive Factors in Breast Cancer by Immunohistochemistry ...
21Connection 9... Page 3. From Us Global Perspectives on the Fight Against Breast Cancer ... Assessment of Prognostic and Predictive Factors in Breast Cancer by Immunohistochemistry ...
22Connection 9... Page 3. From Us Global Perspectives on the Fight Against Breast Cancer ... Assessment of Prognostic and Predictive Factors in Breast Cancer by Immunohistochemistry ...

 

Country selection

Your Dako Account indicates that you are based in , you will be transfered to the web site for

Basket emptied

Your basket was emptied because of the country change.

Country selection

United States of America appears to be your location. To view country specific information on the Dako web site, please accept or change country below.


Dako Cookie Policy
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. Privacy Statement



Get in Touch with Dako in United States of America

  • Pathology Products, Flow Cytometry Products and Specific Proteins
    Dako North America, Inc.

    general@dako.com
    +1 805 566 6655
    +1 805 566 6688

    6392 Via Real
    Carpinteria, CA 93013

  • Flow Cytometry Products
    Fisher Health Care

    +1 800 766 7000
    +1 800 926 1166

    9999 Veterans Memorial Drive
    Houston, TX 77038

Detailed contact information

Submit an Inquiry

How would you like us to follow up?


Your session expired

You have been logged out. Log in again to retrieve your Cart.